Oesophagectomy for early adenocarcinoma and dysplasia arising in Barrett's oesophagus

ANZ Journal of Surgery

Volumn 73, Issue 3, 2003, Pages 121-124

  Thomson, Benjamin N J ^a,b   Cade, Richard J ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b NONE   (Australia)

Author keywords

Adenocarcinoma; Barrett's oesophagus; Dysplasia; Oesophagectomy; Surveillance

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER GRADING; CANCER MORTALITY; CANCER STAGING; CLINICAL ARTICLE; EARLY CANCER; ENDOSCOPIC BIOPSY; EPITHELIUM DYSPLASIA; ESOPHAGUS RESECTION; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MORBIDITY; OUTCOMES RESEARCH; PATIENT MONITORING; PROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT INDICATION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 0037366548     PISSN: 14451433     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1445-2197.2003.02646.x     Document Type: Article

References (22)

1. Drewitz DJ, Sampliner RE, Garewal HS. The incidence of adenocarcinoma in Barrett's esophagus. A prospective study of 170 patients followed for 4.8 years. Am. J. Gastroenterol. 1997; 92: 212-15.
2. Pellegrini CA, Pohl D. High-grade dysplasia in Barrett's esophagus: Surveillance or operation? J. Gastrointest. Surg. 2000; 4: 131-4.
3. Overholt BF, Panjehpour M, Haydek JM. Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. Gastrointest. Endosc. 1999; 49: 1-7.
4. Van Laethem JL, Jogodzinski R, Peny MO, Cremer M, Deviere J. Argon plasma coagulation in the treatment of Barrett's high-grade dysplasia and in situ adenocarcinoma. Endoscopy 2001; 33: 257-61.
5. Overholt BF. Results of photodynamic therapy in Barrett's esophagus: a review. Can. J. Gastroenterol. 1999; 13: 393-6.
6. Ferguson MK, Naunheim KS. Resection for Barrett's mucosa with high-grade dysplasia: implications for prophylactic photodynamic therapy. J. Thorac. Cardiovasc. Surg. 1997; 114: 824-9.
7. Nijhawan PK, Wang KK. Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high-grade dysplasia within Barrett's esophagus. Gastrointest. Endosc. 2000; 52: 440-4.
8. Schnell TG, Sontag SJ, Chejfec G et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology 2001; 120: 1607-19.
9. Spechler SJ. Disputing dysplasia [Editorial]. Gastroenterology 2001; 120: 1864-8.
10. Levine DS, Haggitt RC, Blount PL, Rabinovitch PS, Rusch VW, Reid BJ. An Endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology 1993; 105: 40-50.
11. Reid BJ, Blount PL, Feng Z, Levine DS. Optimizing endoscopic biopsy detection of early cancer in Barrett's high-grade dysplasia. Am. J. Gastroenterol. 2000; 95: 3089-96.
12. Falk GW, Rice TW, Goldblum JR, Richter JE. Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia. Gastrointest. Endosc. 1999; 49: 170-6.
13. Cameron AJ, Carpenter HA. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study. Am. J. Gastroenterol. 1997; 92: 586-91.
14. Cawley HM, Meltzer SJ, De Benedetti VM et al. Anti-p53 antibodies in patients with Barrett's esophagus or esophageal carcinoma can predate cancer diagnosis. Gastroenterology 1998; 115: 19-27.
15. Ireland AP, Clark GW, DeMeester TR. Barrett's esophagus. The significance of p53 in clinical practice. Ann. Surg. 1997; 225: 17-30.
16. Falk GW, Catalano MF, Sivak MV Jr, Rice TW, Van Dam J. Endosonography in the evaluation of patients with Barrett's esophagus and high grade dysplasia. Gastrointest. Endosc. 1994; 40: 207-12.
17. De Backer AI, De Schepper AM, Pelckmans P. The value of medical imaging in uncomplicated and complicated Barrett's esophagus. Acta Gastroenterol. Belgica 2000; 63: 22-8.
18. Buttar NS, Wang KK, Sebo TJ et al. Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. Gastroenterology 2001; 120: 1630-9.
19. Stein HJ. Esophageal cancer: screening and surveillance. Results of a consensus conference held at the VIth World Congress of the International Society for Diseases of the Esophagus. Dis. Esophagus 1996; 9: S3-S19.
20. Zaninotto G, Parenti AR, Ruol A, Costantini M, Merigliano S, Ancona E. Oesophageal resection for high-grade dysplasia in Barrett's oesophagus. Br. J. Surg. 2000; 87: 1102-5.
21. Patti MG, Arcerito M, Feo CV et al. Barrett's esophagus: a surgical disease. J. Gastrointest. Surg. 1999; 3: 397-403.
22. Luketich JD, Schauer PR, Christie NA et al. Minimally invasive esophagectomy. Ann. Thorac. Surg. 2000; 70: 906-11.